127 related articles for article (PubMed ID: 36336001)
1. A Rare But Devastating Dermatologic Manifestation of Ulcerative Colitis.
Kuftinec GN; Lim JE; Yarur AJ
Gastroenterology; 2023 May; 164(6):883-886. PubMed ID: 36336001
[No Abstract] [Full Text] [Related]
2. Immune thrombocytopenia in ulcerative colitis.
Casella G; Antonelli E; Villanacci V; Salemme M; Di Bella C; Baldini V; Bassotti G
Tech Coloproctol; 2016 Jul; 20(7):499-500. PubMed ID: 27137208
[No Abstract] [Full Text] [Related]
3. Tracheobronchitis in ulcerative colitis: a case report of therapeutic response with infliximab and review of the literature.
Horgan L; Mulrennan S; D'Orsogna L; McLean-Tooke A
BMC Gastroenterol; 2019 Nov; 19(1):171. PubMed ID: 31675916
[TBL] [Abstract][Full Text] [Related]
4. Infliximab Efficacy and Safety in an Ulcerative Colitis Patient with Systemic Lupus Erythematosus.
Ben-Horin S; Ungar B; Eliakim R; Langevitz P
J Crohns Colitis; 2016 Jun; 10(6):752-3. PubMed ID: 26826571
[No Abstract] [Full Text] [Related]
5. Infliximab Use in a Child With Ulcerative Colitis and Prior In Utero Exposure to Infliximab.
Lim J; Hammami MB; Mahadevan U
Gastroenterology; 2020 May; 158(6):1834-1835. PubMed ID: 31926172
[No Abstract] [Full Text] [Related]
6. Intensification of maintenance therapy with infliximab in ulcerative colitis.
Casellas F
Rev Esp Enferm Dig; 2015 Sep; 107(9):525-6. PubMed ID: 26334457
[No Abstract] [Full Text] [Related]
7. Lack of efficacy of infliximab in the treatment of primary sclerosing cholangitis in inflammatory bowel diseases in childhood.
Cardile S; Candusso M; Papadatou B; Bracci F; Knafelz D; Torre G
Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):736. PubMed ID: 28441268
[No Abstract] [Full Text] [Related]
8. Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients.
Angelison L; Almer S; Eriksson A; Karling P; Fagerberg U; Halfvarson J; Thörn M; Björk J; Hindorf U; Löfberg R; Bajor A; Hjortswang H; Hammarlund P; Grip O; Torp J; Marsal J; Hertervig E;
Aliment Pharmacol Ther; 2017 Feb; 45(4):519-532. PubMed ID: 28025840
[TBL] [Abstract][Full Text] [Related]
9. [A case of a simple ulcer associated with ulcerative colitis that demonstrated a good clinical response to infliximab].
Kishi M; Sou S; Ishihara H; Terabe H; Yasaka M; Kuhara K; Takeda T; Shimokoube M; Morimitsu Y; Miyazono K
Nihon Shokakibyo Gakkai Zasshi; 2015; 112(9):1682-8. PubMed ID: 26346358
[TBL] [Abstract][Full Text] [Related]
10. Colectomy rates in patients with ulcerative colitis following treatment with infliximab or ciclosporin: a systematic literature review.
Thorne K; Alrubaiy L; Akbari A; Samuel DG; Morrison-Rees S; Roberts SE
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):369-82. PubMed ID: 26825217
[TBL] [Abstract][Full Text] [Related]
11. Rapidly Progressing Aseptic Abscesses in a Patient with Ulcerative Colitis.
Yamaguchi Y; Nakagawa M; Nakagawa S; Nagao K; Inoue S; Sugiyama T; Izawa S; Hijikata Y; Ebi M; Funaki Y; Ogasawara N; Sasaki M; Kasugai K
Intern Med; 2021 Mar; 60(5):725-730. PubMed ID: 32999240
[TBL] [Abstract][Full Text] [Related]
12. Infliximab for ulcerative colitis.
Chey WY; Shah A
J Clin Gastroenterol; 2005; 39(10):920; author reply 920. PubMed ID: 16208122
[No Abstract] [Full Text] [Related]
13. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study.
Danese S; Colombel JF; Lukas M; Gisbert JP; D'Haens G; Hayee B; Panaccione R; Kim HS; Reinisch W; Tyrrell H; Oh YS; Tole S; Chai A; Chamberlain-James K; Tang MT; Schreiber S;
Lancet Gastroenterol Hepatol; 2022 Feb; 7(2):118-127. PubMed ID: 34798038
[TBL] [Abstract][Full Text] [Related]
14. An Unusual Skin Manifestation in a Patient With Ulcerative Colitis.
Dawkins YM; Kanigsberg N; Murthy S
Clin Gastroenterol Hepatol; 2016 Jan; 14(1):A35-6. PubMed ID: 26291668
[No Abstract] [Full Text] [Related]
15. Histological Outcomes and Predictive Value of Faecal Markers in Moderately to Severely Active Ulcerative Colitis Patients Receiving Infliximab.
Magro F; Lopes SI; Lopes J; Portela F; Cotter J; Lopes S; Moreira MJ; Lago P; Peixe P; Albuquerque A; Rodrigues S; Silva MR; Monteiro P; Lopes C; Monteiro L; Macedo G; Veloso L; Camila C; Afonso J; Geboes K; Carneiro F;
J Crohns Colitis; 2016 Dec; 10(12):1407-1416. PubMed ID: 27226417
[TBL] [Abstract][Full Text] [Related]
16. Infliximab is effective in the treatment of ulcerative colitis with dermatomyositis: A case report.
Huang BB; Han LC; Liu GF; Lv XD; Gu GL; Li SQ; Chen L; Wang HQ; Zhan LL; Lv XP
World J Gastroenterol; 2020 Dec; 26(46):7425-7435. PubMed ID: 33362394
[TBL] [Abstract][Full Text] [Related]
17. Tofacitinib for the treatment of acute severe ulcerative colitis refractory to infliximab.
Fortuny Bauzá M; Cañete Pizarro F; Calm Salvans A; Calafat Sard M; Domènech Morral E
Gastroenterol Hepatol; 2022 Apr; 45 Suppl 1():11-12. PubMed ID: 34118322
[No Abstract] [Full Text] [Related]
18. An Old Bridge to the Newer Biologics: Cyclosporine for Rescue Therapy in Acute Severe Ulcerative Colitis.
Ashat D; Jain A; Weaver KN; Long MD; Herfarth HH; Barnes EL
Dig Dis Sci; 2022 Dec; 67(12):5439-5443. PubMed ID: 36125593
[No Abstract] [Full Text] [Related]
19. Serum Levels of Infliximab Biosimilar in a Child Delivered From a Mother Treated for Ulcerative Colitis.
Kawamoto A; Fujii T; Mitani R; Suzuki Y; Yauchi T; Okamoto R
Inflamm Bowel Dis; 2022 Aug; 28(8):1298-1299. PubMed ID: 35700275
[TBL] [Abstract][Full Text] [Related]
20. Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis.
Choy MC; Seah D; Faleck DM; Shah SC; Chao CY; An YK; Radford-Smith G; Bessissow T; Dubinsky MC; Ford AC; Churilov L; Yeomans ND; De Cruz PP
Inflamm Bowel Dis; 2019 Jun; 25(7):1169-1186. PubMed ID: 30605549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
